Entia, a medical technology business, which recently announced a commercial partnership with Pfizer UK, raised $12 million earlier in the year in a funding round co-led by UK growth capital investor, BGF and growth fund manager, Parkwalk, with participation from existing seed investor Sussex Place Ventures.